Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 80 results for "claris lifesciences"

Claris Lifesciences gains on MHRA nod for new plant
Business Standard

Claris Lifesciences receives MHRA approval for New Plant

As on 30th June 2014, the company had approvals of 13 ANDAs in US, 14 molecules in the Europe and 11 molecules in Other Regulated Markets (ORM), additionally, there are 28 ANDAs in the US, 8 molecules in Europe and 10 molecules in ORM, which are ... Web Newswire, 1 week ago
[x]  

2 images for "claris lifesciences"

Business Standard, 3 weeks ago
Moneycontrol.com, 2 months ago
Business Standard India

CLARIS LIFESCIENCES : POSTS Rs15 CRORE PROFIT IN Q2

Claris Lifesciences Ltd has reported net profit of Rs15 crore for Apr- Jun 2014 ( Rs18 crore for Apr- Jun 2013 ). Its revenues have declined to Rs151 crore ( Rs202 crore ). The company had transferred its infusion business in India and emerging ...
 4 Traders1 month ago Claris Lifesciences net declines by 14.7% in Q2  PharmaBiz1 month ago Claris Life consolidated Jun '14 sales at Rs 156.35 crore  Money Control1 month ago Claris Life consolidated net profit at Rs 15.4 cr in June 14  Business Standard India1 month ago
[x]  

Claris Lifesciences appoints Milina Bose as director

Claris Lifesciences at its meeting held on August 11, 2014, has approved and taken on record the appointment of Ms. Milina Bose as an Additional Non Executive Non Independent Woman Director w.e.f. August 11, 2014 on Board of the Company.
 Money Control1 month ago Claris Lifesciences: Updates on outcome of AGM  Money Control2 months ago Outcome of board meeting of Claris Lifesciences  Business Standard2 months ago Claris Lifesciences: Outcome of board meeting  Money Control2 months ago

Claris Lifesciences shares up 3.5% on BSE

Stock of Claris Life ended the day 3.56 per cent higher at Rs 181.60 on the BSE. In intra-day, it gained 6.33 per cent to Rs 186.45. ");document.close();})();' frameborder="0" scrolling="no" width="640" height="160"> On the volume front, 2.25 lakh shares of ...
 Economic Times4 weeks ago Claris Lifesciences shares up 3.5 per cent on BSE  Economic Times4 weeks ago Claris Lifesciences shares up over 3% on BSE  Business Standard2 months ago

Claris Lifesciences extends Thursday's gains

Claris Lifesciences rose 2.15% to Rs 185.50 at 9:19 IST on BSE, with the stock extending Thursday's 3.56% gains triggered by the company receiving MHRA nod for its newly commissioned plant. Meanwhile, the S&P BSE Sensex was up 109.08 points or ...
 Capital Market4 weeks ago

Claris Lifesciences Q2 PAT at Rs 2,841 mn

Claris Lifesciences EBITDA for H1CY14 stood at Rs. 570 million. Claris Lifesciences Ltd. announced its quarterly and half yearly un-audited financial results for the quarter and half year ended 30th June 2014 at its board meeting held at its registered office ...
 India Infoline1 month ago Claris Lifesciences posts Rs 1,511 million revenue at Q2CY14  Express Pharma1 month ago CLARIS LIFESCIENCES LIMITED UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30th JUNE 2014  Web Newswire1 month ago
Money Control

Claris Lifesciences facility receives USFDA's positive nod

US drug regulator termed Claris' facility as acceptable after the inspection
 Business Standard2 months ago USFDA finds Claris Lifesciences plant acceptable  Business Standard2 months ago Claris Lifesciences advances as USFDA finds plant acceptable  India Infoline2 months ago US FDA finds Claris Lifesciences plant acceptable; stock up 4%  Business Standard2 months ago

Claris Lifesciences stock surges 3%

It's earnings season. www.indiainfoline.com, a part of the IIFL Group, presents you real-time, comprehensive, and in-depth analysis of company earnings to give you that investment edge. The 'Results Calendar' helps you keep track of all important results. The ...
 India Infoline2 months ago Pre-Budget Expectation: Claris Lifesciences  India Infoline2 months ago

Claris Lifesciences spurts after board OKs transferring speciality injectable biz

Claris Lifesciences jumped 5.03% to Rs 167 at 15:19 IST on BSE after the company said its board approved transferring the speciality injectable business by way of a slump sale to a wholly-owned subsidiary of the company.
 Business Standard2 months ago

UK MHRA approves Cbris Lifesciences new facility

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Claris Lifesciences newly commissioned facility (Plant 2). The latest approval will pave for Cbris Lifesciences to improve capacities to develop in the regulated ...
 Pharmaceutical Business Review4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less